Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Gross Margin (2019 - 2025)

Historic Gross Margin for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to 81.14%.

  • Biodesix's Gross Margin rose 41600.0% to 81.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 79.82%, marking a year-over-year increase of 20900.0%. This contributed to the annual value of 78.17% for FY2024, which is 46700.0% up from last year.
  • Latest data reveals that Biodesix reported Gross Margin of 81.14% as of Q3 2025, which was up 41600.0% from 79.86% recorded in Q2 2025.
  • Over the past 5 years, Biodesix's Gross Margin peaked at 81.14% during Q3 2025, and registered a low of 36.89% during Q1 2021.
  • Moreover, its 5-year median value for Gross Margin was 72.73% (2023), whereas its average is 68.0%.
  • As far as peak fluctuations go, Biodesix's Gross Margin plummeted by -320900bps in 2021, and later surged by 232700bps in 2022.
  • Biodesix's Gross Margin (Quarter) stood at 65.49% in 2021, then rose by 0bps to 65.59% in 2022, then grew by 17bps to 77.0% in 2023, then increased by 2bps to 78.75% in 2024, then grew by 3bps to 81.14% in 2025.
  • Its Gross Margin stands at 81.14% for Q3 2025, versus 79.86% for Q2 2025 and 79.38% for Q1 2025.